#USA #Werfen #Bedford #Edison Award #GEM Premier 7000

Werfen's Recognition at the Edison Awards

Werfen, a leader in specialized diagnostics, has recently been honored as the Silver Winner of the prestigious Edison Award in the Emergency and On-Site Health Solutions category. This recognition is specifically for their groundbreaking GEM Premier 7000 with Intelligent Quality Management 3 (iQM3) blood gas testing system, which has been heralded as an innovative solution that introduces hemolysis detection right at the point of care.

A Milestone in Innovation

The Edison Awards are well-respected globally, celebrating excellence in innovation, product development, and human-centered design. Companies that receive this accolade are recognized for their impactful contributions to various fields, with winners chosen by a diverse body of esteemed academics and leaders in the innovation sector.

"We are incredibly proud to receive the Edison Award, which reflects our unwavering commitment to innovation within the domain of Specialized Diagnostics," stated Remo Tazzi, Vice President of Worldwide Marketing and Service at Werfen. He explained that detecting hemolysis in blood samples, which can adversely affect potassium results, presents a significant challenge that had remained unsolved until now. Through the ingenious work of Werfen's scientists, the patented technology of the GEM Premier 7000 with iQM3 has emerged, showcasing its potential to significantly improve patient outcomes.

Understanding Hemolysis and Its Impact

The introduction of hemolysis detection at the point of care is critical, as up to 70% of preanalytical errors in blood testing are attributed to this issue. Hemolysis occurs when the membranes of red blood cells rupture, leading to the leakage of cellular contents into the surrounding fluid. This unintended consequence can dramatically alter potassium levels, causing false readings that jeopardize appropriate patient care. In fact, potassium levels can appear deceptively normal in cases of hemolysis, while those that are genuinely low may show as elevated.

Such complications can contribute to prolonged hospital stays, unnecessary health care costs, and misguided patient management.

Efficiency and Precision Delivered

The GEM Premier 7000 system's innovative approach to hemolysis detection sets a new standard in the industry. Within just 45 seconds, the system can identify hemolysis while providing a broad spectrum of results including pH levels, pCO2, pO2, sodium, potassium, ionized calcium, and more—all essential in timely and accurate patient assessment. The detection mechanism utilizes Werfen's proprietary blood separation and detection technology that has set this product apart in emergency and critical care environments.

Enhancing this capability is the iQM3 quality management system, an automated process that continuously oversees sample quality, ensuring consistency by effectively identifying and correcting preanalytical errors like hemolysis, micro-clots, and bubbles. By maintaining a rigorous check on sample integrity throughout the analysis, the GEM Premier 7000 guarantees reliable results and supports improved decision-making in clinical settings.

Moreover, the system's all-in-one GEM PAK™ cartridge simplifies complex procedures while accommodating diverse testing needs across clinical contexts. By streamlining workflows, the GEM Premier 7000 becomes a vital asset for health care professionals striving for operational excellence.

Continuing a Commitment to Better Patient Care

As part of Werfen's comprehensive Acute Care Diagnostics portfolio, the GEM Premier 7000 with iQM3 serves as an extension of their long-standing reputation in advancing medical technology for improved patient care. This system joins other notable offerings such as the GEM Premier 5000, which previously set benchmarks with the introduction of IntraSpect™, a feature that performs continual quality checks throughout the testing process.

Werfen remains focused on its mission to empower clinicians and laboratory professionals with tools that help drive better clinical decisions, enhance care efficiency, and reduce the overall cost of healthcare delivery in hospitals. From surgical suites to emergency departments, their intelligent systems are instrumental in elevating patient management standards.

The GEM Premier 7000 with iQM3 system is an impressive milestone in Werfen's history and highlights their commitment to innovation in the health care landscape. Although this advanced system is predominantly available in the U.S., Werfen's continued efforts reflect a global aspiration for improved health diagnostics and outcomes.

With the acknowledgment from the Edison Awards, Werfen reaffirms its leadership in the healthcare equipment sector, setting ambitious benchmarks for the future of patient care.